(Q43952711)

28 November 2017

title

Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival (English)

1 reference

28 November 2017

1 reference

Christian Ewelt

1

1 reference

28 November 2017

Mathias Goeppert

2

1 reference

28 November 2017

Marion Rapp

3

1 reference

28 November 2017

Hans-Jakob Steiger

4

1 reference

28 November 2017

Walter Stummer

5

1 reference

28 November 2017

Michael Sabel

6

1 reference

28 November 2017

publication date

16 October 2010

1 reference

Journal of Neuro-Oncology

28 November 2017

published in

1 reference

28 November 2017

volume

103

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

611-618

1 reference

Age and radiation response in glioblastoma multiforme.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

The survival impact of postoperative infection in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

A prospective study on glioblastoma in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Patient age, histologic features, and length of survival in patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Survival after stereotactic biopsy of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Patterns of care in elderly glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Prognosis and patterns of care in elderly patients with glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

The limited value of cytoreductive surgery in elderly patients with malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Up-front temozolomide in elderly patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Treatment of malignant gliomas in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Glioblastoma multiforme-report of 267 cases treated at a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Glioblastoma--the consequences of advanced patient age on treatment and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Cost-effectiveness versus cost-utility analysis of interventions for cancer: does adjusting for health-related quality of life really matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Debulking or biopsy of malignant glioma in elderly people - a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Management of patients aged >60 years with malignant glioma: good clinical status and radiotherapy determine outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0429-9

Malignant gliomas in older adults with poor prognostic signs. Getting nowhere, and taking a long time to do it.

21 January 2018

1 reference

12 December 2020

Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

The treatment of elderly patients with high-grade gliomas

1 reference

12 December 2020

Prognostic factors other than the performance status and age for glioblastoma multiforme: a single-institution experience.

1 reference

12 December 2020

10.1007/S11060-010-0429-9

Identifiers

DOI

1 reference

Dimensions Publication ID

28 November 2017

1020596443

0 references

1 reference